A minimal role for synonymous variation in human disease.

Area of Science:

• Genetics
• Genomics
• Molecular Biology

Background:

• Synonymous mutations alter DNA sequence without changing protein amino acid sequence.
• While some synonymous mutations affect RNA splicing and stability, most human variants are considered neutral or weakly deleterious.
• Recent yeast studies suggest synonymous mutations may be as critical as nonsynonymous ones in disease causation.

Purpose of the Study:

• To evaluate the significance of synonymous mutations in human genetic disease.
• To assess the validity of claims that synonymous mutations are as important as nonsynonymous mutations in causing human diseases based on yeast study findings.

Main Methods:

• Review of existing human genetics studies.
• Analysis of mutagenesis screens.
• Examination of evolutionary data.
• Critique of recent yeast-based findings and their applicability to humans.

Main Results:

• Extensive research in human genetics and evolutionary analyses consistently demonstrates the predominant neutrality of synonymous variants.
• Notable exceptions exist, but they do not invalidate the general trend.
• The direct translation of yeast study findings to human disease causation by synonymous mutations is not supported by current evidence.

Conclusions:

• There is insufficient evidence to support the claim that synonymous mutations are as important as nonsynonymous mutations in causing human diseases.
• The established body of knowledge on the predominant neutrality of synonymous variants in the human genome remains robust.
• Further research is needed to fully understand the role of synonymous mutations, but current data do not warrant a paradigm shift.